Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Health investors roll out unwelcome mat for Amazon's arrival

01/30/2018 | 08:00pm EDT

NEW YORK (Reuters) - As press releases go, it was vague and brief — six paragraphs, 394 words in all. In general terms, it described the beginnings of an effort by three big U.S. companies to team up to improve their employees' healthcare services and save money.

But it delivered a $69 billion body blow to stocks across the healthcare sector, driven in large part because of the first word: "Amazon."

The day long feared by executives and investors alike in the $3.47 trillion U.S. healthcare sector had arrived. And with an unsettling lack of specificity.

"Everyone is still terrified of Amazon," said Jeff Jonas, a portfolio manager focusing on healthcare for Gabelli Funds.

Earlier on Tuesday, Amazon.com Inc (>> Amazon.com), Berkshire Hathaway (>> Berkshire Hathaway) and JPMorgan Chase & Co (>> JP Morgan Chase & Company) announced they will form a healthcare company aimed at cutting costs for their more than 500,000 U.S. employees.

Investors for months have fretted over a potential Amazon entry into healthcare delivery, particularly selling prescription drugs, with stocks periodically selling off on headlines anticipating a move by the massive online retailer.

But Tuesday's news was short on details, creating the potential for the uncertainty over Amazon's healthcare aims to linger over the sector.

“The release that we have today is very cryptic and broad,” said John Schroer, U.S. healthcare sector head for Allianz Global Investors in San Francisco.

"This is just one move amongst perhaps many more that Amazon could take in moving into the retail chain of drug delivery. I doubt it’s the only thing they are going to do," he said.

Among stocks in the drug supply chain, pharmacy benefit manager Express Scripts Holding Co (>> Express Scripts Holding Co) was down 3.3 percent in midafternoon, drug-store chain CVS Health Corp (>> CVS Health) was down 4.1 percent, and pharmaceutical distributor McKesson Corp (>> McKesson Corporation) was down 3 percent.

Health insurers, which had been relatively immune from previous Amazon-related jitters, were clobbered. Cigna Corp (>> Cigna) was down 7.2 percent, Anthem Inc (>> Anthem Inc) slumped 5.3 percent and UnitedHealth Group (>> UnitedHealth Group) declined 4.2 percent, making it the biggest single drag on the blue-chip Dow Jones Industrial Average <.DJI>.

The news sent the S&P 500 healthcare sector <.SPXHC> down 2 percent in Tuesday afternoon trading, putting the group on pace for its biggest single-day decline since October 2016 and blunting the sector's strong momentum to start the year.

Through Monday, healthcare had risen 10.5 percent already in 2018, the best performance among all major sectors and well ahead of the 6.7 percent rise for the overall S&P 500 <.SPX>.

"Healthcare had been outperforming the market, at least year to date," Jonas said. "It’s always a good excuse to sell and take some profit.”

Jonas and others pointed to reasons the healthcare sector should be able to move past the Amazon threat, including a healthy climate for dealmaking that has particularly boosted biotech shares, benefits from U.S. tax reform, and a solid economy leading to use of medical services.

Others shrugged off the Amazon announcement. RBC Capital Markets analyst George Hill, who covers drug distributors, said the initiative at first glance seems to have little market clout to impact healthcare costs and did not seem to be able to displace established players.

"If this was the Amazon announcement drug supply chain investors have been fearing since early 2017," Hill wrote in a research note, "consider us relieved."

(Reporting by Lewis Krauskopf; Editing by Matthew Lewis)

By Lewis Krauskopf

© Reuters 2018
Stocks mentioned in the article
ChangeLast1st jan.
AMAZON.COM, INC. 0.51% 3656.64 Delayed Quote.12.27%
ANTHEM, INC. -0.52% 382.29 Delayed Quote.19.06%
BERKSHIRE HATHAWAY INC. 0.29% 419000 Delayed Quote.20.47%
BEST INC. -7.32% 1.14 Delayed Quote.-44.12%
CIGNA CORPORATION 0.28% 232.88 Delayed Quote.11.86%
CVS HEALTH CORPORATION 0.77% 83.27 Delayed Quote.21.92%
DEERE & COMPANY 0.96% 354.7 Delayed Quote.30.58%
DJ INDUSTRIAL 0.68% 35061.55 Delayed Quote.13.78%
JPMORGAN CHASE & CO. -0.19% 150.64 Delayed Quote.18.78%
JUST GROUP PLC 0.78% 97 Delayed Quote.38.77%
MCKESSON CORPORATION 1.81% 202.63 Delayed Quote.16.51%
NASDAQ 100 1.15% 15111.790895 Delayed Quote.15.92%
NASDAQ COMP. 1.04% 14836.991139 Delayed Quote.13.94%
S&P 500 1.01% 4411.79 Delayed Quote.16.28%
TEAM, INC. -0.87% 5.68 Delayed Quote.-47.89%
UNITEDHEALTH GROUP 0.46% 417.7 Delayed Quote.18.56%
All news about AMAZON.COM, INC.
07/23AMAZON COM : Two Amazon summer reading programs inspire kids to love books
07/23T ROWE PRICE : EV startup Rivian announces $2.5 bln funding round led by Amazon,..
07/23Big tech companies retake market reins with earnings on tap
07/23Wall Street extends rally, S&P, Nasdaq on course for record closing highs
07/23STREET COLOR : Amazon Confirms Interest in Accepting Cryptocurrency: Business In..
07/23AMAZON COM : Dutch teen on space flight told Bezos he had never ordered from Ama..
07/23SCREENSHOT : Have Bezos and Branson ushered in a new era of space tourism?
07/23S.Korean stocks end higher on earnings optimism
07/23AMAZON COM : India court quashes Amazon, Walmart's Flipkart bid to stall antitru..
07/23AMAZON COM : India court quashes Amazon, Walmart's Flipkart bid to stall antitru..
More news
Financials (USD)
Sales 2021 490 B - -
Net income 2021 29 050 M - -
Net cash 2021 78 508 M - -
P/E ratio 2021 65,6x
Yield 2021 -
Capitalization 1 844 B 1 844 B -
EV / Sales 2021 3,61x
EV / Sales 2022 3,00x
Nbr of Employees 1 298 000
Free-Float 82,4%
Duration : Period :
Amazon.com, Inc. Technical Analysis Chart | AMZN | US0231351067 | MarketScreener
Technical analysis trends AMAZON.COM, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 53
Last Close Price 3 656,64 $
Average target price 4 249,73 $
Spread / Average Target 16,2%
EPS Revisions
Managers and Directors
Jeffrey P. Bezos Chairman, President & Chief Executive Officer
Brian T. Olsavsky Chief Financial Officer & Senior Vice President
Patricia Q. Stonesifer Independent Director
Thomas O. Ryder Independent Director
Jonathan Jake Rubinstein Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
AMAZON.COM, INC.12.27%1 715 437
JD.COM, INC.-17.76%121 018
WAYFAIR INC.26.44%33 500
ETSY, INC.17.40%23 522
ALLEGRO.EU SA-13.64%17 380